Kimberly-Clark is acquiring Kenvue's consumer health business, which includes Listerine and Neutrogena staples, following Kenvue's spin-off from J&J.
3 reports, 2 independent
Updated Aug 31
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kimberly-Clark is acquiring Kenvue's consumer health business, which includes Listerine and Neutrogena staples, following Kenvue's spin-off from J&J.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Kenvue, spun off from J&J, is trading on Nasdaq amid pending acquisition by Kimberly-Clark.1 source
- Kimberly-Clark is acquiring Kenvue in a buyout, which includes the sale of Neutrogena and the inclusion of Listerine in Essential Health sales.Sub-event
KMB is acquiring Kenvue's consumer health business following the spin-off from J&J.1 source
Keep exploring
Part of
Johnson & Johnson successfully spun off Kenvue to focus on core business, while FED policy signals affect market perception of JNJ.Also in this story
- Market discussion on CNBC regarding business trends, market pullbacks, and potential entry points for companies like J&J, Kenvue, PepsiCo, and Constellation Brands.
- Leadership changes and strategic growth agenda are underway at Kenvue, including a move involving Banati.
The entities involved
-
Kimberly-Clark
American multinational company
-
Kenvue
American consumer health company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer